{
    "Overall_score": {
        "Correlation": 7,
        "Sentiment": 5,
        "Importance": 6,
        "Impact": 6,
        "Duration": 4,
        "Virality": 3,
        "Source_Score": 7,
        "Specificity": 6,
        "Sector_Spread": 5,
        "Tech_Mentions": 2
    },
    "Each_item": [
        {
            "News_content": "RT @DewDiligence: $MRK Perlmutter not exuding confidence in $IDIX nuke—even talked about using Sofosbuvir instead. Sounds like IDIX nuke no…",
            "Correlation": 9,
            "Sentiment": 3,
            "Importance": 7,
            "Impact": 6,
            "Duration": 3,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 9,
            "Sector_Spread": 4,
            "Tech_Mentions": 1
        },
        {
            "News_content": ".@SnupSnus Maybe $MRK will end up deriving some value from $IDIX IP. If not, looks like a big asset writedown in coming at some point.",
            "Correlation": 8,
            "Sentiment": 2,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 2,
            "Source_Score": 6,
            "Specificity": 7,
            "Sector_Spread": 3,
            "Tech_Mentions": 1
        },
        {
            "News_content": "High-profile #Bristol-Myers cancer immunotherapy #Opdivo disappoints, shares off via @Reuters #Keytruda $BMY $MRK",
            "Correlation": 7,
            "Sentiment": 4,
            "Importance": 8,
            "Impact": 7,
            "Duration": 5,
            "Virality": 6,
            "Source_Score": 9,
            "Specificity": 8,
            "Sector_Spread": 7,
            "Tech_Mentions": 2
        },
        {
            "News_content": "RT @megtirrell: Januvia meets primary goal of TECOS cardiovascular outcomes trial, $MRK says",
            "Correlation": 8,
            "Sentiment": 7,
            "Importance": 7,
            "Impact": 6,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 8,
            "Specificity": 8,
            "Sector_Spread": 4,
            "Tech_Mentions": 1
        },
        {
            "News_content": "#earnings Before Market $F est $0.25,prev $0.29, $COH est $0.35, prev $0.40, $PFE est $0.50, Prev $0.52 , $MRK est $0.74",
            "Correlation": 6,
            "Sentiment": 5,
            "Importance": 5,
            "Impact": 4,
            "Duration": 2,
            "Virality": 2,
            "Source_Score": 7,
            "Specificity": 6,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "RT @matthewherper: How Big Can $MRK's Keytruda Be In Lung Cancer? ...Perlmutter vs. Pazdur?",
            "Correlation": 8,
            "Sentiment": 6,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 7,
            "Sector_Spread": 6,
            "Tech_Mentions": 2
        },
        {
            "News_content": "$AET $MRK US Stocks Turn Slightly Higher",
            "Correlation": 4,
            "Sentiment": 5,
            "Importance": 3,
            "Impact": 3,
            "Duration": 2,
            "Virality": 1,
            "Source_Score": 5,
            "Specificity": 3,
            "Sector_Spread": 4,
            "Tech_Mentions": 1
        },
        {
            "News_content": "“The integration of Cubist is fortifying our growth platform in Hospital Acute Care. “-@AdamHSchechter $MRK",
            "Correlation": 7,
            "Sentiment": 8,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 8,
            "Specificity": 7,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        }
    ]
}